1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
(
- Contribution to journal › Article
- 2010
-
Mark
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
(
- Contribution to journal › Article
- 1994
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
- 1993
-
Mark
MMM as second line treatment for advanced breast cancer. Evidence of cross-resistance with antracyclines
(
- Contribution to journal › Published meeting abstract
- 1992
-
Mark
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
(
- Contribution to journal › Article
-
Mark
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
(
- Contribution to journal › Article
-
Mark
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
(
- Contribution to journal › Article